Items where authors include "Potter, V."

Article

Kulasekararaj, A. orcid.org/0000-0003-3180-3570, Cavenagh, J., Dokal, I. et al. (14 more authors) (2024) Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology guideline. British Journal of Haematology. ISSN 0007-1048

Waszczuk-Gajda, A., Gras, L., de Wreede, L.C. orcid.org/0000-0002-7667-9369 et al. (22 more authors) (2023) Safety and efficacy of autologous stem cell transplantation in dialysis-dependent myeloma patients—the DIADEM study from the chronic malignancies working party of the EBMT. Bone Marrow Transplantation. pp. 1-6. ISSN 0268-3369

Galleu, A., Milojkovic, D., Deplano, S. et al. (21 more authors) (2019) Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival. British Journal of Haematology, 185 (1). pp. 89-92. ISSN 0007-1048

Chouaid, C., Danson, S. orcid.org/0000-0002-3593-2890, Andreas, S. et al. (15 more authors) (2018) Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness study. Lung Cancer, 124. pp. 310-316. ISSN 0169-5002

Andreas, S., Chouaid, C., Danson, S. orcid.org/0000-0002-3593-2890 et al. (15 more authors) (2018) Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS). Lung Cancer, 124. pp. 298-309.

Arriola, E., Wheater, M., Galea, I. et al. (13 more authors) (2016) Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer. Journal of Thoracic Oncology, 11 (9). pp. 1511-1521. ISSN 1556-0864

Proceedings Paper

Robin, M., Iacobelli, S., Passweg, J.R. et al. (22 more authors) (2023) Treosulfan vompared to Busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the chronic malignancies working party of the EBMT. In: Blood. 65th ASH Annual Meeting, 09-12 Dec 2023, San Diego, California, USA. American Society of Hematology , p. 473.